AWM
CUE icon

Angeles Wealth Management’s Cue Biopharma CUE Stock Holding History

Angeles Wealth Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Sell
7,000
-3,333
-32% -$75.4K 0.01% 469
2026
Q1 		$71.3K Hold
10,333
– – ﹤0.01% 459
2025
Q4 		$94.7K Buy
10,333
+6,333
+158% +$116K 0.01% 401
2025
Q3 		$86.2K Hold
4,000
– – 0.01% 363
2025
Q2 		$81.9K Buy
+4,000
New +$85.3K 0.01% 366

Other funds holding CUE

RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Angeles Wealth Management's CUE Position: Q2 2026 in Review

Angeles Wealth Management reduced its Cue Biopharma (CUE) stake by 32% in Q2 2026, selling an estimated $75.4K and leaving 7,000 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #469.

Angeles Wealth Management first reported a position in CUE in Q2 2025 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Angeles Wealth Management held 7,000 shares of Cue Biopharma worth $221K as of Q2 2026.
  • Angeles Wealth Management sold 3,333 Cue Biopharma shares in Q2 2026, an estimated $75.4K.
  • Cue Biopharma made up 0.01% of Angeles Wealth Management's portfolio in Q2 2026, its #469 holding.
  • Angeles Wealth Management first reported a position in Cue Biopharma in Q2 2025 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.